Incidence, risk factors, and outcomes of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: A systematic review and meta-analysis

被引:3
|
作者
Bai, Jiang [1 ]
Yin, Xinyu [2 ]
Li, Jiaqi [2 ]
Li, Jia-Qi [2 ]
Niu, Yanna [2 ]
Li, Zhenhua [2 ]
Li, Jing [2 ]
Zhou, Yun [1 ,3 ]
机构
[1] Shanxi Med Univ, Hosp 5, Shanxi Prov Peoples Hosp, Dept Nephrol, Taiyuan, Shanxi, Peoples R China
[2] Shanxi Med Univ, Clin Med Coll 2, Taiyuan, Shanxi, Peoples R China
[3] Shanxi Med Univ, Hosp 5, Shanxi Prov Peoples Hosp, Dept Nephrol, Taiyuan 030001, Shanxi, Peoples R China
关键词
focal segmental glomerulosclerosis; kidney transplantation; meta-analysis; pediatrics; risk factors; RENAL-TRANSPLANTATION; DISEASE RECURRENCE; CHILDREN; POSTTRANSPLANTATION; EXPERIENCE; ALLOGRAFTS;
D O I
10.1111/ctr.15119
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundFocal segmental glomerulosclerosis is the most prevalent acquired kidney disease leading to end-stage renal disease in children and has a propensity for recurring in the transplanted kidney. The recurrence of FSGS after kidney transplantation in children varies greatly. In addition, the risk factors and outcomes of recurrence of FSGS remain controversial. This study evaluated the recurrence rate, risk factors, and prognosis of FSGS after kidney transplantation in order to provide advice and assistance in clinical decision-making for pediatric kidney transplantation.MethodsPubMed, Embase, Web of Science, CNKI, and other databases were searched from the establishment of the repository to March 2022. We extracted data on incidence, risk factors, and outcomes.ResultsThe results showed that the recurrence rate of primary FSGS in children after renal transplantation was 48% (95% CI 36%-59%) and the recurrence rate of FSGS (all forms) was 35% (95% CI 17%-52%). The graft loss rate of primary FSGS in children after kidney transplantation was 29% (95% CI 17%-42%) and the graft loss rate of FSGS (all forms) was 29% (95% CI 4%-62%). 57% (95% CI 42%-73%) of pediatric patients with recurrent primary FSGS showed complete remission. Risk factor analyses showed that age of onset (SMD .69, 95% CI .20-1.19, p = .006) was related to the recurrence of primary FSGS, whereas the living related donor was not a risk factor for recurrent primary FSGS in pediatrics after kidney transplantation (OR 1.22, 95% CI .48-3.10, p = .674).ConclusionsThe recurrence rate and graft loss rate of FSGS in children after kidney transplantation were relatively high. Age at onset was associated with a risk for recurrent primary FSGS, whereas the living related donor was not a risk factor for recurrent FSGS in pediatric kidney recipients.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Impact of pre-transplant malignancy on outcomes in kidney transplant recipients: an updated meta-analysis with systematic review
    Zhang, He
    Hu, Xiaopeng
    WORLD JOURNAL OF UROLOGY, 2024, 43 (01)
  • [22] Effects of exercise training on cardiovascular risk factors in kidney transplant recipients: a systematic review and meta-analysis
    Chen, Gang
    Gao, Liu
    Li, Xuemei
    RENAL FAILURE, 2019, 41 (01) : 408 - 418
  • [23] Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient
    Cho, Jang-Hee
    Lee, Jong-Hak
    Park, Ga-Young
    Lim, Jeong-Hoon
    Kim, Jun-Seop
    Kang, Yoon-Jung
    Kwon, Owen
    Choi, Ji-Young
    Park, Sun-Hee
    Kim, Yong-Lim
    Kim, Hyung-Kee
    Huh, Seung
    Kim, Chan-Duck
    RENAL FAILURE, 2014, 36 (04) : 623 - 626
  • [24] RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN PEDIATRIC RENAL-TRANSPLANT RECIPIENTS - SUCCESSFUL TREATMENT WITH ORAL CYCLOPHOSPHAMIDE
    KERSHAW, DB
    SEDMAN, AB
    KELSCH, RC
    BUNCHMAN, TE
    CLINICAL TRANSPLANTATION, 1994, 8 (06) : 546 - 549
  • [25] The Symptoms and Impact of Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Conceptual Model of the Patient Experience
    Marci English
    Emily Hawryluk
    Robert Krupnick
    Mysore S. A. Kumar
    Jason Schwartz
    Advances in Therapy, 2019, 36 : 3390 - 3408
  • [26] Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis
    Juhi Kumar
    Ibrahim F. Shatat
    Amy L. Skversky
    Robert P. Woroniecki
    Marcela Del Rio
    Eduardo M. Perelstein
    Valerie L. Johnson
    Shefali Mahesh
    Pediatric Nephrology, 2013, 28 : 333 - 338
  • [27] The Symptoms and Impact of Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Conceptual Model of the Patient Experience
    English, Marci
    Hawryluk, Emily
    Krupnick, Robert
    Kumar, Mysore S. A.
    Schwartz, Jason
    ADVANCES IN THERAPY, 2019, 36 (12) : 3390 - 3408
  • [28] European Society of Pediatric Nephrology survey on current practice regarding recurrent focal segmental glomerulosclerosis after pediatric kidney transplantation
    Bouts, Antonia
    Veltkamp, Floor
    Toenshoff, Burkhard
    Vivarelli, Marina
    PEDIATRIC TRANSPLANTATION, 2019, 23 (03)
  • [29] Combination of pulse methylprednisolone infusions with cyclosporine-based immunosuppression is safe and effective to treat recurrent focal segmental glomerulosclerosis after pediatric kidney transplantation
    Shishido, Seiichiro
    Satou, Hiroyuki
    Muramatsu, Masaki
    Hamasaki, Yuko
    Ishikura, Kenji
    Hataya, Hiroshi
    Honda, Masataka
    Asanuma, Hiroshi
    Aikawa, Atsushi
    CLINICAL TRANSPLANTATION, 2013, 27 (02) : E143 - E150
  • [30] Intensive and Prolonged Treatment of Focal and Segmental Glomerulosclerosis Recurrence in Adult Kidney Transplant Recipients: A Pilot Study
    Canaud, G.
    Zuber, J.
    Sberro, R.
    Royale, V.
    Anglicheau, D.
    Snanoudj, R.
    Gaha, K.
    Thervet, E.
    Lefrere, F.
    Cavazzana-Calvo, M.
    Noel, L. -H.
    Mejean, A.
    Legendre, Ch.
    Martinez, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (05) : 1081 - 1086